Diabetes drug dulaglutide may reduce symptoms of depression

FHS
March 8, 2024
11:03 am

The current study highlighted the antidepressant effects of dulaglutide using the CMS depression model. Notably, the potential metabolisms that underlie the antidepressant effect of dulaglutide have been elucidated in this study.

MHRA approves GSK’s RSV vaccine for older adults in the UK – Pharmaceutical Technology

Each year in the UK, RSV is estimated to cause 14,000 hospitalisations and 8,000 deaths in adults ages 60 and over. Image credit: Shutterstock/Phawat Older

July 10, 2023

Most Johns Hopkins Med Students Will Receive Free Tuition, Thanks to $1 Billion Gift

Most medical students at Johns Hopkins University will no longer pay tuition, thanks to a $1 billion gift from Bloomberg Philanthropies announced Monday. Starting in

July 9, 2024

Study investigates the sustainability in blood pressure reduction through a 12-month lifestyle intervention

The sustainability and scalability of limited duration interventions in low- and middle-income countries remain unclear.

June 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.